MSN Pharmaceuticals, Inc. et al. vs. Breckenridge Pharmaceutical, Inc.

Explore the PTAB proceeding IPR2025-01107 filed by MSN Pharmaceuticals, Inc. et al. on 2025-06-06. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-01107

Filing Date

2025-06-06

Accorded Filing Date

2025-06-06

Institution Decision Date

2025-10-17

Last Modified Date

2025-11-18

Proceeding Type

IPR

Termination Date

2025-10-17

Trial Status

Discretionary Denial

Parties & Counsel

Petitioner

MSN Pharmaceuticals, Inc. et al.

Represented By

Torabi, Noorossadatet al

Patent Owner / Respondent

Breckenridge Pharmaceutical, Inc.

Represented By

Larsen, Andrewet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 14379613

Respondent Patent Number 11013729

External Links

Espacenet

Google Patents

Respondent Inventor Pratibha S. Pilgaonkar et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

75 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name MERCHANT & GOULD P.C.

Customer Number —

Address P.O. BOX 2903, MINNEAPOLIS, MN, 55402-0903, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
28510	Erich Gess	703-684-2511
30247	John Clifford	480-725-8806
32344	Bruce Boggs Jr	703-684-2515
32960	Brian Batzli	612-336-4755
33280	Gregory Sebald	612-336-4728
34130	Steven Bruess	612-336-4711
34994	Dennis Daley	612-332-5300
36414	Julie Daulton	612-336-4724
37703	John Reich	612-332-5300
37948	Kevin Swanson	612-336-4735
39721	Scott Johnston	612-371-5274
39828	David Schmaltz	612-336-4617
39998	Mark Gleason	612-371-5354
40443	James Larson	612-455-3805
42719	John Kern	703-413-3000
43361	Tong Wu	612-336-4611
44481	William Hughet	703-518-4505
45255	Anthony Zeuli	612-371-5208
45518	Daniel Pereira	703-413-3000
45774	Melissa Hayworth	703-684-2522
46551	Jonathan Berschadsky	212-223-7241
50471	Robert Kalinsky	612-336-4771
50640	Daniel Stier	404-954-5100
53188	Thomas Leach Iii	612-336-4665
53214	George Lewis	303-357-1670
54434	Anneliese Mayer	612-332-5300
55478	Tarik Nabi	703-668-8000
55573	James Rieke	612-349-5746
55868	Daniel Evans	404-954-5061
58356	Chad Wickman	612-252-1543
58884	Jeffrey Blake	404-954-5040
58911	Alpaslan Sapmaz	612-766-6093
59315	Andrew Larsen	212-223-6658
59325	Todd Obijeski	404-954-5072
59572	Heather Kroona	612-332-5300
62303	Benjamin Tramm	612-332-5300
62529	Andrew Lagatta	612-371-5383
63431	Julie Skoge	612-336-4628
66010	Kenneth Heywood	651-508-0857
66251	Alexander Zumbulyadis	612-336-4607
67805	Benjamin Graf	212-223-6651
69238	Daniel Bruzzone	612-336-4781
69422	Christian Hansen	612-349-3019
69677	Ian Mcfarland	865-380-5960
70043	T. Johnson	612-371-5281
70627	Joseph Dubis	612-371-5381
71113	Robert Sykes	720-259-4572
72503	Luciano Ricondo	212-223-6526
72535	James Denker	651-621-4117
74188	Kristen Souther	303-357-1208
74243	Jeffrey Klenc	404-954-5062
74302	Heather Chatterton	612-371-5392
75501	Ryan Fletcher	303-357-1670
75619	Sarah Wilkening	404-885-2753
76380	Lea Westman	212-223-6520
77928	Saalini Sekar	612-766-6005
78082	Kristen Lewis	612-336-4783
78876	Andrew Nemecek	952-232-9874
79152	Brian Monahon	803-640-2581
79271	Gabrielle Kiefer	920-915-5599
79335	Rhett Sexton	865-380-5962
79380	Katherine Mares	612-332-5300
79777	Taylor Stemler	952-334-7090
79876	Jenna Logsdon	813-974-0994
79886	Kelsey Covert	989-859-4948
800052	Yidi Wu	201-204-8028
80665	Zachary Kezlo	612-336-4630
80819	Erin Herdeman	612-361-0309
81173	Matthew Metcalfe	303-357-1206
81662	Benjamin Dooley	865-380-5960
81733	Payton Remick	404-954-5031
82487	Zachary Zadow	612-462-8417
82755	Yechao Dai	703-518-4514
83133	Sophia Vogeler	612-336-4660
L0799	Kamal Arvind	404-954-5039

Proceeding Documents

Director Discretionary Decision: Deny RESPONSE

2025-10-17 FILING PARTY: BOARD

Download

2016

March 11, 2014 Braun's Declaration Exhibit

2025-09-25 FILING PARTY: PATENT OWNER

Download

Petitioners' Opposition to Patent Owner's Request for Discretionary Denial RESPONSE

2025-09-25 FILING PARTY: PETITIONER

Download

Patent Owner's Updated Exhibit List NOTICE

2025-09-25 FILING PARTY: PATENT OWNER

Download

Preliminary Response by Patent Owner POPR

2025-09-25 FILING PARTY: PATENT OWNER

Download

MSN Pharmaceuticals, Inc. et al. vs. Breckenridge Pharmaceutical, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

MSN Pharmaceuticals, Inc. et al.

Represented By

Patent Owner / Respondent

Breckenridge Pharmaceutical, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Director Discretionary Decision: Deny RESPONSE

March 11, 2014 Braun's Declaration Exhibit

Petitioners' Opposition to Patent Owner's Request for Discretionary Denial RESPONSE

Patent Owner's Updated Exhibit List NOTICE

Preliminary Response by Patent Owner POPR

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Order Resetting Deadlines, D.I. 101 Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Defendants’ Initial Invalidity Contentions Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Plaintiff’s Final Infringement Contentions Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Defendants’ Requests for Production Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Scheduling Order, D.I. 31 Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Plaintiff’s Requests for Admission Exhibit

Docket Report: Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Plaintiff’s Requests for Production Exhibit

Brief in Support of Patent Owner's Request for Discretionary Denial RESPONSE

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Defendants’ First Supplemental Invalidity Contentions (select portions) Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Defendants’ Responses to Plaintiff’s Request for Production Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Defendants’ Interrogatories to Plaintiff Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Markman Order, D.I. 96 Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Complaint Exhibit

Breckenridge Pharmaceutical, Inc. v. Hetero USA Inc. et al., No. 24-cv-571 (GBW) (D. Del.). Plaintiff’s Interrogatories to Defendants Exhibit

March 24, 2025 Chief APJ Boalick Memo: Guidance on USPTO's recission of "Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation" Exhibit

Notice: Mandatory Notice NOTICE

Notice: Power of Attorney NOTICE

Notice: Notice filing date accorded NOTICE

Supplemental Certificate of Service of Petition for Inter Partes Review OTHER

Ex. 1011 - Aulton Pharmaceutics Exhibit

Ex. 1014 - FDA Approved Label for Pradaxa (October 2010) Exhibit

Ex. 1004 - US Appl. No. 18356642 - file history Exhibit

Ex. 1007 - US20060183779 (Brauns) Exhibit

Ex. 1001 - US11013729 Exhibit

Ex. 1017 - Dissolution methods for Dabi Etexilate Mesylate Exhibit

Ex. 1019 - FDA Paragraph IV Patent Certifications (06/15/2020) Exhibit

Ex. 1012 - Lavanya June 2011 (Pelletization Technology - A Quick Review) Exhibit

Ex. 1015 - Stangier (Dabi Pharmacokinetics) Exhibit

Ex. 1024 - Stewart Memorandum Exhibit

Ex. 1008 - File History of U.S. Appl. No. 11-381,890 Exhibit

Ex. 1005 - Declaration of Maureen D. Donovan, Ph.D. Exhibit

Ex. 1006 - Curriculum Vitae of Maureen D. Donovan, Ph.D. Exhibit

Ex. 1023 - Remington Chapter 45 Exhibit

Ex. 1002 - US11013729 - file history Exhibit

Ex. 1009 - US20060115525 (Leane) Exhibit

IPR Petition (729) PETITION

Ex. 1016 - FDA Guidance re. IR Dissolution Testing (1997) Exhibit

Petitioners' Power of Attorney NOTICE

Ex. 1010 - US20040109890 (Sugimoto) Exhibit

Ex. 1022 - WO2012001156A2 Exhibit

Ex. 1021 - US20080069891 (Habib - abuse proof dosage forms) Exhibit

Ex. 1018 - AU dabi etexilate clinical study (2011 - BI formulation) Exhibit

Ex. 1020 - US11013729 Assignments Exhibit

Ex. 1003 - US Appl. No. 17241793 - file history Exhibit